Jefferies Downgrades Abivax (ABVX) to Hold

June 2, 2026 1:03 AM

Jefferies analyst Faisal Khurshid downgraded Abivax (NASDAQ: ABVX) from Buy to Hold with a price target of $90.00 (from $160.00).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found